Related Experiment Videos
Monitoring thrombolytic therapy
E G Bovill1, R Becker, R P Tracy
1Department of Pathology, College of Medicine, University of Vermont, Burlington, VT 05405.
Progress in Cardiovascular Diseases
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Genetic variants associated with protein C levels.
Journal of thrombosis and haemostasis : JTH·2013
Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindred.
Journal of thrombosis and haemostasis : JTH·2011
The endothelial microenvironment in the venous valvular sinus: thromboresistance trends and inter-individual variation.
Histochemistry and cell biology·2011
Risk factors for peripheral venous disease resemble those for venous thrombosis: the San Diego Population Study.
Journal of thrombosis and haemostasis : JTH·2010
A genetic basis for the interrelation of coagulation factors.
Journal of thrombosis and haemostasis : JTH·2007
Attitudes toward genetic testing for thrombophilia in asymptomatic members of a large family with heritable protein C deficiency.
Journal of thrombosis and haemostasis : JTH·2005
Aficamten is associated with improvements in cardiac mechanics in obstructive hypertrophic cardiomyopathy: Results from FOREST-HCM.
Progress in cardiovascular diseases·2026
Joint associations of Interleukin-6 and apolipoprotein B with major adverse cardiovascular events in the UK biobank.
Progress in cardiovascular diseases·2026
Obesity, lipids, inflammation, and healthy aging.
Progress in cardiovascular diseases·2026
Revascularization options for managing patients with multi-vessel coronary artery disease.
Progress in cardiovascular diseases·2026
Prognostic Role of Blood Inflammatory Composite Biomarkers in Dvt After Lower Extremity Fractures.
The Iowa orthopaedic journal·2026
Pattern of blood utilization and blood wastage at blood bank of a tertiary care hospital in Lahore.
Pakistan journal of medical sciences·2026
Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial.
Research and practice in thrombosis and haemostasis·2026
Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies.
Research and practice in thrombosis and haemostasis·2026